Rapkin Group, Inc. v. Cardinal Ventures, Inc.

29 N.E.3d 752, 2015 Ind. App. LEXIS 268, 2015 WL 1450163
CourtIndiana Court of Appeals
DecidedMarch 31, 2015
DocketNo. 18A02-1408-CT-563
StatusPublished
Cited by13 cases

This text of 29 N.E.3d 752 (Rapkin Group, Inc. v. Cardinal Ventures, Inc.) is published on Counsel Stack Legal Research, covering Indiana Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rapkin Group, Inc. v. Cardinal Ventures, Inc., 29 N.E.3d 752, 2015 Ind. App. LEXIS 268, 2015 WL 1450163 (Ind. Ct. App. 2015).

Opinion

MATHIAS, Judge.

[1] Rapkin Group, Inc. (“Rapkin”) appeals the order of the Delaware Circuit Court granting summary judgment in favor of Cardinal Ventures, Inc. (“Cardinal”), in a shareholder derivative suit brought by Rapkin on behalf of The Eye Center1 Group, LLC (“ECG”) and Surgi-center Group, LLC (“SCG”) against Cardinal, in which Cardinal was alleged to have breached a fiduciary duty and committed constructive fraud upon ECG and SCG. On appeal, Rapkin claims that genuine issues of material fact precluded the grant of summary judgment.

[2] 1 We reverse and remand.

Facts and Procedural History

[3] The underlying facts of this case were set forth in our earlier, memorandum decision involving the same lawsuit:

ECG/SCG are closely-held, limited liability companies incorporated in April of 1994.1 Cardinal Health Partners (“Cardinal Health”)2 owned 21.93% of ECG and 33.07% of SCG. The balance of the shares between the two companies were owned by ophthalmologists and optometrists, including Rapkin, whose principal member is Dr. Jeffrey Rapkin (“Dr. Rapkin”). Dr. Roch was chief executive officer of ECG/SCG from its founding in 1994 until July 31, 1999. ECG/SCG had two long time employees: D. Frank [Winconek] (“[Winconek]”),3 who held [755]*755the positions of assistant administrator and director of finance before being promoted to chief executive officer, and Stephanie Carrick (“Carrick”), who held many positions with ECG/SCG culminating with her appointment as the company’s chief financial officer. Dr. Watkins joined ECG/SCG in 2004 and was invited to become an owner and a member of the board of directors in December of 2005.
Around July of 2007, some of the ophthalmologists and optometrists voiced a desire to share in more of the companies’ profits because of the amount of work they were doing. Hoping to improve relations within the company, Cardinal Health sold some of its shares to the ophthalmologists and optometrists. Rapkin purchased additional shares at this time. Dr. Roch did not sell any of his shares to the ophthalmologists and optometrists nor did he purchase any shares offered by Cardinal Health.
Blue and Co., LLC (“Blue”) performed yearly audits of ECG/SCG’s finances. The usual practice was for Blue to -present its findings to [Winconek] and Car-rick. [Winconek] and Carrick would then report those findings to the board of directors. In 2007, Blue submitted the 2006 financial report after April 15th, causing some physicians to file extensions for their tax returns. Though the reports were submitted late, [Winco-nek] and Carrick mentioned no problems when presenting the report to the board of directors.
ECG/SCG hired a new auditing firm in 2008; Katz, Sapper & Miller (“KSM”). On March 14, 2008, KSM submitted a partial financial report for 2007. This was due in part to ECG/SCG converting their accounting methods. After the board received the completed report, Dr. Watkins reviewed it with her husband and noticed some inconsistencies. Because of those inconsistencies, Dr. Watkins sent an email to [Winconek] and Carrick with questions about the report. She also requested to see ECG/ SCG’s current balance sheets. About the same time, ECG/SCG began experiencing difficulties paying quarterly salaries and dividends on time. [Winconek] and Carrick told the board of directors that the problems were due to accounting errors and delayed payments from commercial payers. Dr. Watkins did not receive the requested balance sheets until around November 2008. At the same time, [Winconek] sent an email to the board of directors expressing confidence in the finances of the company. However, Dr. Watkins’s review of the balance sheets she received showed inconsistencies in the companies’ debt to equity ratio.
In January of 2009, Dr. Watkins and fellow board director Robert Gilder-sleeve (“Gildersleeve”) spent several hours reviewing the balance sheets. Their review led them to talk to KSM directly about the companies’ finances. On or about January 12, 2009, [Winco-nek]’s administrative assistant, Melita Flowers, informed Dr. Watkins that a staff accountant at ECG/SCG had hired an attorney to discuss concerns about the financial practices at the companies. On January 29, 2009, Dr. Watkins spoke with Jennifer Abrell (“Abrell”), counsel for ECG/SCG. Dr- Watkins wanted to set up a meeting with the accountants at KSM to discuss ECG/SCG’s financial state. Abrell informed Dr. Watkins that KSM also desired to meet with company leadership to discuss its concerns about [Winconek] and Carrick.
On February 3, 2009, Dr. Watkins, Gil-dersleeve, and Abrell met with KSM. KSM conveyed its concerns regarding [756]*756improper accounting practices to the board of directors. KSM told the directors that it would need access to all of ECG/SCG’s accounting records to confirm its suspicions. The next day, the board of directors placed [Winco-nek] on personal leave and gave KSM all of the information requested to perform its investigation. The directors and a representative of KSM also met with Carrick. At that meeting, Carrick revealed that she and [Winconek] engaged in fraudulent practices with the companies’ finances. KSM’s investigation revealed that the company had no cash on hand, little available lines of credit for operations, and flawed financial reporting. Specifically, KSM found that the financial reports for ECG/SCG contained intentionally overstated figures for accounts receivable, inventory, and unapplied cash. ECG and SCG had been insolvent since December 2006 and July 2008 respectively. Proceeds from loans rather than profits from company operations were used to pay salaries and dividends, making shares in the company virtually worthless. The board of directors terminated [Winconek] on February 18, 2009 and Carrick on March 13, 2009.

Rapkin Grp., Inc. v. Roch, 6 N.E.3d 505, 2014 WL 808866 at **1-2, No. 18A02-1302-CT-193, (Ind.Ct.App. Feb. 27, 2014), trans. denied (“Rapkin I ”).4

[4] Rapkin filed a complaint on April 28, 2010, alleging that Dr. Roch, Dr. Watkins, Cardinal, Winconek, Carrick, and Blue’s “willful misconduct, recklessness, breach of fiduciary duty, mismanagement and/or fraud” caused Rapkin to lose the value of its investment in the LLCs. On the defendants’ motion, the trial court dismissed this claim as a direct action, and Rapkin thereafter filed an amended complaint as a shareholder derivative action but with substantially the same claims.

[5] Several of the defendants filed motions for summary judgment. At issue in our earlier decision was the motion for summary judgment filed by Drs. Roch and Watkins on April 7, 2012. The trial court granted this motion for summary judgment, and Rapkin appealed. In our memorandum decision, we affirmed the trial court’s judgment, concluding that the designated evidence demonstrated: (1) that Dr. Roch5 made no statement that was relied upon by Rapkin; (2) that Dr. Roch did not know about the LLCs’ precarious financial situation or the fraudulent acts committed by Winconek and Carrick; and (3) that neither Dr. Roch nor Dr. Watkins breached a fiduciary duty to Rapkin. Id. at 9-13.

[6] On March 26, 2013, after our memorandum decision in Rapkin I was issued, Cardinal filed a motion for summary judgment.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Samuel C. Arp, II v. Indiana State Police
Indiana Court of Appeals, 2025
Erika Butler v. Symmergy Clinic
Indiana Court of Appeals, 2020
Charles B. Eldredge v. Susan M. Ruch
Indiana Court of Appeals, 2020
BloomBank v. United Fidelity Bank F.S.B.
113 N.E.3d 708 (Indiana Court of Appeals, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
29 N.E.3d 752, 2015 Ind. App. LEXIS 268, 2015 WL 1450163, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rapkin-group-inc-v-cardinal-ventures-inc-indctapp-2015.